2-[4-[6-[4-(5-chloro-2,4-difluorophenyl)-1H-imidazol-5-yl]-1,5-naphthyridin-3-yl]pyrazol-1-yl]-N-methylethanamine

C23H18ClF2N7 — CID 146662042

IUPAC2-[4-[6-[4-(5-chloro-2,4-difluorophenyl)-1H-imidazol-5-yl]-1,5-naphthyridin-3-yl]pyrazol-1-yl]-N-methylethanamine
SMILESCNCCn1cc(-c2cnc3ccc(-c4[nH]cnc4-c4cc(Cl)c(F)cc4F)nc3c2)cn1
InChIInChI=1S/C23H18ClF2N7/c1-27-4-5-33-11-14(10-31-33)13-6-21-19(28-9-13)2-3-20(32-21)23-22(29-12-30-23)15-7-16(24)18(26)8-17(15)25/h2-3,6-12,27H,4-5H2,1H3,(H,29,30)
InChIKeyUHJAWSVSVLASKY-UHFFFAOYSA-N
MW465.90 g/mol
LogP4.70
Rot. Bonds6

About 2-[4-[6-[4-(5-chloro-2,4-difluorophenyl)-1H-imidazol-5-yl]-1,5-naphthyridin-3-yl]pyrazol-1-yl]-N-methylethanamine

2-[4-[6-[4-(5-chloro-2,4-difluorophenyl)-1H-imidazol-5-yl]-1,5-naphthyridin-3-yl]pyrazol-1-yl]-N-methylethanamine (PubChem CID 146662042) has the molecular formula C23H18ClF2N7 and a molecular weight of 465.90 g/mol. Its IUPAC name is 2-[4-[6-[4-(5-chloro-2,4-difluorophenyl)-1H-imidazol-5-yl]-1,5-naphthyridin-3-yl]pyrazol-1-yl]-N-methylethanamine.

Molecular Properties

Compound Name2-[4-[6-[4-(5-chloro-2,4-difluorophenyl)-1H-imidazol-5-yl]-1,5-naphthyridin-3-yl]pyrazol-1-yl]-N-methylethanamine
PubChem CID146662042
Molecular FormulaC23H18ClF2N7
Molecular Weight465.90 g/mol
Exact Mass465.13
IUPAC Name2-[4-[6-[4-(5-chloro-2,4-difluorophenyl)-1H-imidazol-5-yl]-1,5-naphthyridin-3-yl]pyrazol-1-yl]-N-methylethanamine
SMILESCNCCn1cc(-c2cnc3ccc(-c4[nH]cnc4-c4cc(Cl)c(F)cc4F)nc3c2)cn1
InChIInChI=1S/C23H18ClF2N7/c1-27-4-5-33-11-14(10-31-33)13-6-21-19(28-9-13)2-3-20(32-21)23-22(29-12-30-23)15-7-16(24)18(26)8-17(15)25/h2-3,6-12,27H,4-5H2,1H3,(H,29,30)
InChIKeyUHJAWSVSVLASKY-UHFFFAOYSA-N
XLogP4.70
TPSA84.31 Ų
H-Bond Donors2
H-Bond Acceptors6
Rotatable Bonds6
Heavy Atoms33
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500465.90
LogP ≤ 54.70
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 106

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'halogenated_ring_1', 'substructure': 'N/A'}

Analyze 2-[4-[6-[4-(5-chloro-2,4-difluorophenyl)-1H-imidazol-5-yl]-1,5-naphthyridin-3-yl]pyrazol-1-yl]-N-methylethanamine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 2-[4-[6-[4-(5-chloro-2,4-difluorophenyl)-1H-imidazol-5-yl]-1,5-naphthyridin-3-yl]pyrazol-1-yl]-N-methylethanamine?
The IUPAC name of 2-[4-[6-[4-(5-chloro-2,4-difluorophenyl)-1H-imidazol-5-yl]-1,5-naphthyridin-3-yl]pyrazol-1-yl]-N-methylethanamine (CID 146662042) is 2-[4-[6-[4-(5-chloro-2,4-difluorophenyl)-1H-imidazol-5-yl]-1,5-naphthyridin-3-yl]pyrazol-1-yl]-N-methylethanamine.
What is the SMILES notation for 2-[4-[6-[4-(5-chloro-2,4-difluorophenyl)-1H-imidazol-5-yl]-1,5-naphthyridin-3-yl]pyrazol-1-yl]-N-methylethanamine?
The canonical SMILES for 2-[4-[6-[4-(5-chloro-2,4-difluorophenyl)-1H-imidazol-5-yl]-1,5-naphthyridin-3-yl]pyrazol-1-yl]-N-methylethanamine is CNCCn1cc(-c2cnc3ccc(-c4[nH]cnc4-c4cc(Cl)c(F)cc4F)nc3c2)cn1.
What is the InChIKey of 2-[4-[6-[4-(5-chloro-2,4-difluorophenyl)-1H-imidazol-5-yl]-1,5-naphthyridin-3-yl]pyrazol-1-yl]-N-methylethanamine?
The InChIKey is UHJAWSVSVLASKY-UHFFFAOYSA-N. The full InChI is InChI=1S/C23H18ClF2N7/c1-27-4-5-33-11-14(10-31-33)13-6-21-19(28-9-13)2-3-20(32-21)23-22(29-12-30-23)15-7-16(24)18(26)8-17(15)25/h2-3,6-12,27H,4-5H2,1H3,(H,29,30).
What are the key properties of 2-[4-[6-[4-(5-chloro-2,4-difluorophenyl)-1H-imidazol-5-yl]-1,5-naphthyridin-3-yl]pyrazol-1-yl]-N-methylethanamine?
2-[4-[6-[4-(5-chloro-2,4-difluorophenyl)-1H-imidazol-5-yl]-1,5-naphthyridin-3-yl]pyrazol-1-yl]-N-methylethanamine has a molecular weight of 465.90 g/mol, XLogP of 4.70, 6 rotatable bonds, 2 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[4-[6-[4-(5-chloro-2,4-difluorophenyl)-1H-imidazol-5-yl]-1,5-naphthyridin-3-yl]pyrazol-1-yl]-N-methylethanamine is sourced from PubChem (CID 146662042), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).